PIMIDES I: a pilot study to assess the feasibility of patient-controlled neurostimulation with the EASEE® system to treat medically refractory focal epilepsy

The study design of PIMIDES, a trial based on patient-individualized transcranial electric neurostimulation of epileptic foci, is reported. Inclusion criteria include a predominant epileptic focus and pharmacoresistance to two antiepileptic drug treatments. The study is prospective, unblinded, and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kravalis, Kristina, Schulze-Bonhage, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Clinical Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650046/
https://www.ncbi.nlm.nih.gov/pubmed/33324921
http://dx.doi.org/10.1186/s42466-020-00061-5
_version_ 1783607438689173504
author Kravalis, Kristina
Schulze-Bonhage, Andreas
author_facet Kravalis, Kristina
Schulze-Bonhage, Andreas
author_sort Kravalis, Kristina
collection PubMed
description The study design of PIMIDES, a trial based on patient-individualized transcranial electric neurostimulation of epileptic foci, is reported. Inclusion criteria include a predominant epileptic focus and pharmacoresistance to two antiepileptic drug treatments. The study is prospective, unblinded, and serves to assess the safety of subgaleal implantation and transcranial stimulation.
format Online
Article
Text
id pubmed-7650046
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76500462020-12-14 PIMIDES I: a pilot study to assess the feasibility of patient-controlled neurostimulation with the EASEE® system to treat medically refractory focal epilepsy Kravalis, Kristina Schulze-Bonhage, Andreas Neurol Res Pract Clinical Trial Protocol The study design of PIMIDES, a trial based on patient-individualized transcranial electric neurostimulation of epileptic foci, is reported. Inclusion criteria include a predominant epileptic focus and pharmacoresistance to two antiepileptic drug treatments. The study is prospective, unblinded, and serves to assess the safety of subgaleal implantation and transcranial stimulation. BioMed Central 2020-06-02 /pmc/articles/PMC7650046/ /pubmed/33324921 http://dx.doi.org/10.1186/s42466-020-00061-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Trial Protocol
Kravalis, Kristina
Schulze-Bonhage, Andreas
PIMIDES I: a pilot study to assess the feasibility of patient-controlled neurostimulation with the EASEE® system to treat medically refractory focal epilepsy
title PIMIDES I: a pilot study to assess the feasibility of patient-controlled neurostimulation with the EASEE® system to treat medically refractory focal epilepsy
title_full PIMIDES I: a pilot study to assess the feasibility of patient-controlled neurostimulation with the EASEE® system to treat medically refractory focal epilepsy
title_fullStr PIMIDES I: a pilot study to assess the feasibility of patient-controlled neurostimulation with the EASEE® system to treat medically refractory focal epilepsy
title_full_unstemmed PIMIDES I: a pilot study to assess the feasibility of patient-controlled neurostimulation with the EASEE® system to treat medically refractory focal epilepsy
title_short PIMIDES I: a pilot study to assess the feasibility of patient-controlled neurostimulation with the EASEE® system to treat medically refractory focal epilepsy
title_sort pimides i: a pilot study to assess the feasibility of patient-controlled neurostimulation with the easee® system to treat medically refractory focal epilepsy
topic Clinical Trial Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650046/
https://www.ncbi.nlm.nih.gov/pubmed/33324921
http://dx.doi.org/10.1186/s42466-020-00061-5
work_keys_str_mv AT kravaliskristina pimidesiapilotstudytoassessthefeasibilityofpatientcontrolledneurostimulationwiththeeaseesystemtotreatmedicallyrefractoryfocalepilepsy
AT schulzebonhageandreas pimidesiapilotstudytoassessthefeasibilityofpatientcontrolledneurostimulationwiththeeaseesystemtotreatmedicallyrefractoryfocalepilepsy

Ejemplares similares